Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 143, 112166
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2020M672603)
- China Postdoctoral Science Foundation (2020M682686)
- Guangzhou University of Chinese Medicine (A1-AFD018201A26)
This publication has 27 references indexed in Scilit:
- Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver TransplantationTransplantation, 2019
- Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive roleNature Communications, 2018
- Generation of a multi‐functional, target organ‐specific, anti‐fibrotic molecule by molecular engineering of the extracellular matrix protein, decorinBritish Journal of Pharmacology, 2018
- Ursolic Acid, a Natural Nutraceutical Agent, Targets Caspase3 and Alleviates Inflammation‐Associated Downstream Signal TransductionMolecular Nutrition & Food Research, 2017
- Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2017
- Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic reviewObesity Reviews, 2017
- Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damageAsian Pacific Journal of Tropical Medicine, 2016
- Decorin as a multivalent therapeutic agent against cancerAdvanced Drug Delivery Reviews, 2016
- Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenicProceedings of the National Academy of Sciences, 2015
- Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stressFood & Function, 2015